METHODS AND COMPOSITIONS FOR DETECTING AND MODULATING O-GLYCOSYLATION
申请人:Gross Benjamin
公开号:US20100290987A1
公开(公告)日:2010-11-18
The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for identifying therapeutic compounds to treat glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such as insulin resistance, nephropathy, microvascular damage, and endothelial dysfunction. The invention is also useful for identifying therapeutic compounds to treat de-glycosylation-associated disorders such as ischemic damage and traumatic injury. The invention also relates in part to assays that are useful for identifying and testing candidate compounds for modulating glycosylation of proteins and also relates in part to compounds to treat glycosylation-associated diseases and disorders.
US8524444B2
申请人:——
公开号:US8524444B2
公开(公告)日:2013-09-03
US8993718B2
申请人:——
公开号:US8993718B2
公开(公告)日:2015-03-31
[EN] METHODS AND COMPOSITIONS FOR DETECTING AND MODULATING O-GLYCOSYLATION<br/>[FR] PROCÉDÉS ET COMPOSITIONS DE DÉTECTION ET DE MODULATION DE O-GLYCOSYLATION
申请人:HARVARD COLLEGE
公开号:WO2008156676A1
公开(公告)日:2008-12-24
[EN] The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for identifying therapeutic compounds to treat glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such as insulin resistance, nephropathy, microvascular damage, and endothelial dysfunction. The invention is also useful for identifying therapeutic compounds to treat de-glycosylation-associated disorders such as ischemic damage and traumatic injury. The invention also relates in part to assays that are useful for identifying and testing candidate compounds for modulating glycosylation of proteins and also relates in part to compounds to treat glycosylation-associated diseases and disorders. [FR] La présente invention concerne des procédés et des produits permettant de moduler la glycosylation de protéines. L'invention se révèle utile pour identifier des composés thérapeutiques destinés à traiter des troubles associés à la glycosylation, tels qu'une neurodégénérescence, le diabète, notamment les complications du diabète telles qu'une résistance à l'insuline, une néphropathie, une lésion microvasculaire et un dysfonctionnement endothélial. L'invention se révèle également utile pour identifier des composés thérapeutiques destinés à traiter des troubles associés à une déglycosylation, tels qu'une lésion ischémique et une lésion traumatique. L'invention concerne également partiellement des essais qui se révèlent utiles pour identifier et tester des composés candidats permettant de moduler la glycosylation de protéines et elle concerne également partiellement des composés destinés à traiter des maladies et des troubles associés à la glycosylation.
Tolstyakov; Pevzner; Tselinskii, Russian Journal of General Chemistry, 2000, vol. 70, # 9, p. 1458 - 1465